374 related articles for article (PubMed ID: 10025864)
21. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
[TBL] [Abstract][Full Text] [Related]
22. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
Domloge-Hultsch N; Utecht L; James W; Yancey KB
Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
[TBL] [Abstract][Full Text] [Related]
24. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
25. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
26. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
27. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
[TBL] [Abstract][Full Text] [Related]
29. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).
Olivry T; Borrillo AK; Xu L; Dunston SM; Slovis NM; Affolter VK; Demanuelle TC; Chan LS
Vet Immunol Immunopathol; 2000 Jan; 73(1):45-52. PubMed ID: 10678397
[TBL] [Abstract][Full Text] [Related]
30. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
[TBL] [Abstract][Full Text] [Related]
31. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
32. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens.
Yoon KH; Kim SC; Kang DS; Lee IJ
Eur J Dermatol; 2000; 10(3):212-4. PubMed ID: 10725820
[TBL] [Abstract][Full Text] [Related]
33. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
34. [New aspects on the pathogenesis of bullous pemphigoid].
Schmidt E; Bröcker EB; Zillikens D
Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
Nakatani C; Muramatsu T; Shirai T
Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
[TBL] [Abstract][Full Text] [Related]
36. A case of bullous pemphigoid with antidesmoplakin autoantibodies.
Watanabe K; Hashimoto T; Ishiko A; Shimizu H; Nishikawa T
Dermatology; 1994; 189 Suppl 1():126-8. PubMed ID: 8049553
[TBL] [Abstract][Full Text] [Related]
37. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
38. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
39. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid.
Delaporte E; Dubost-Brama A; Ghohestani R; Nicolas JF; Neyrinck JL; Bergoend H; Janin A; Capron M
J Immunol; 1996 Oct; 157(8):3642-7. PubMed ID: 8871665
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
